138 related articles for article (PubMed ID: 23486588)
1. Effect of AMPD1 gene polymorphism on muscle activity in humans.
Fedotovskaya ON; Danilova AA; Akhmetov II
Bull Exp Biol Med; 2013 Feb; 154(4):489-91. PubMed ID: 23486588
[TBL] [Abstract][Full Text] [Related]
2. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes.
Ginevičienė V; Jakaitienė A; Pranculis A; Milašius K; Tubelis L; Utkus A
BMC Genet; 2014 May; 15():58. PubMed ID: 24885427
[TBL] [Abstract][Full Text] [Related]
3. Is the C34T polymorphism of the AMPD1 gene associated with athlete performance in rowing?
Ciȩszczyk P; Eider J; Ostanek M; Leońska-Duniec A; Ficek K; Kotarska K; Girdauskas G
Int J Sports Med; 2011 Dec; 32(12):987-91. PubMed ID: 22105616
[TBL] [Abstract][Full Text] [Related]
4. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
Rico-Sanz J; Rankinen T; Joanisse DR; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C;
Physiol Genomics; 2003 Jul; 14(2):161-6. PubMed ID: 12783984
[TBL] [Abstract][Full Text] [Related]
5. Effect of creatine supplementation on physical performance are related to the AMPD1 and PPARG genes polymorphisms in football players.
Lifanov D; Khadyeva MN; Rahmatullina LSh; Demenev SV; Ibragimov RR
Ross Fiziol Zh Im I M Sechenova; 2014 Jun; 100(6):767-76. PubMed ID: 25665401
[TBL] [Abstract][Full Text] [Related]
6. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Safranow K; Suchy J; Jakubowska K; Olszewska M; Bińczak-Kuleta A; Kurzawski G; Rzeuski R; Czyżycka E; Łoniewska B; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
J Appl Genet; 2011 Feb; 52(1):67-76. PubMed ID: 21108053
[TBL] [Abstract][Full Text] [Related]
7. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
[TBL] [Abstract][Full Text] [Related]
8. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
Feng AF; Liu ZH; Zhou SL; Zhao SY; Zhu YX; Wang HX
BMC Cardiovasc Disord; 2017 Jul; 17(1):174. PubMed ID: 28673246
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms influencing muscle phenotypes in North-African and Spanish populations.
Fernández-Santander A; Valveny N; Harich N; Kandil M; Luna F; Martín MÁ; Rubio JC; Lucia A; Gaibar M
Ann Hum Biol; 2012 Mar; 39(2):166-9. PubMed ID: 22324844
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the AMPD1 C34T polymorphism in Polish power-oriented athletes.
Cieszczyk P; Ostanek M; Leońska-Duniec A; Sawczuk M; Maciejewska A; Eider J; Ficek K; Sygit K; Kotarska K
J Sports Sci; 2012; 30(1):31-5. PubMed ID: 22017426
[TBL] [Abstract][Full Text] [Related]
11.
Leońska-Duniec A; Maculewicz E; Humińska-Lisowska K; Maciejewska-Skrendo A; Leźnicka K; Cięszczyk P; Sawczuk M; Trybek G; Wilk M; Lepionka W; Ficek K
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32429460
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?
Rubio JC; Martín MA; Rabadán M; Gómez-Gallego F; San Juan AF; Alonso JM; Chicharro JL; Pérez M; Arenas J; Lucia A
J Appl Physiol (1985); 2005 Jun; 98(6):2108-12. PubMed ID: 15677729
[TBL] [Abstract][Full Text] [Related]
13. Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients.
Nemati R; Lu J; Ramachandran V; Etemad A; Heidari M; Yahya MJ; Roozafzoon R; Ismail P
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323204
[TBL] [Abstract][Full Text] [Related]
14. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
15. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
[TBL] [Abstract][Full Text] [Related]
16. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
Goodarzi MO; Taylor KD; Guo X; Quiñones MJ; Cui J; Li X; Hang T; Yang H; Holmes E; Hsueh WA; Olefsky J; Rotter JI
Diabetes; 2005 Apr; 54(4):1222-7. PubMed ID: 15793265
[TBL] [Abstract][Full Text] [Related]
17. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
[TBL] [Abstract][Full Text] [Related]
18. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
[TBL] [Abstract][Full Text] [Related]
19. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
[TBL] [Abstract][Full Text] [Related]
20. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle.
Norman B; Mahnke-Zizelman DK; Vallis A; Sabina RL
J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
